MercedesEGonzalezMD

Dermatology • Miami Beach, FL

Acne & Rosacea, Pediatric Dermatology

Director, Pediatric Dermatology of Miami

Join to view full profile

Dr. Gonzalez is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gonzalez's full profile

Already have an account?

Office
4308 Alton Rd
Ste 750
Miami Beach, FL 33140
Phone+1 917-309-3214

Education & Training

NYU Grossman School of MedicineResidency, Dermatology, 2008 - 2011
New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2004 - 2007
Rutgers New Jersey Medical SchoolClass of 2004

Certifications & Licensure

FL State Medical License 2007 - 2026
NY State Medical License 2006 - 2013
American Board of Dermatology Dermatology
American Board of Dermatology Pediatric Dermatology

Publications & Presentations

PubMed

Long-Term Safety and Efficacy with Roflumilast Cream 0.15% in Patients Aged ≥6 Years with Atopic Dermatitis: A Phase 3 Open-Label Extension Trial.
Eric L Simpson, Lawrence F Eichenfield, Kim A Papp, Seth B Forman, Adelaide A Hebert
Dermatitis. 2025-01-10
1 citations
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa.
Amy S Paller, Shireen V Guide, Diego Ayala, Mercedes E Gonzalez, Anne W Lucky
The Journal of Dermatological Treatment. 2024-12-01
Roflumilast Cream, 0.15%, for Atopic Dermatitis in Adults and Children: INTEGUMENT-1 and INTEGUMENT-2 Randomized Clinical Trials.
Eric L Simpson, Lawrence F Eichenfield, Javier Alonso-Llamazares, Zoe D Draelos, Laura K Ferris
JAMA Dermatology. 2024-11-01